Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston
boston blog main
boston top stories
dna
2
×
life sciences
national blog main
national top stories
san francisco blog main
2
×
san francisco top stories
agios therapeutics
azacitidine
base editing
beta-thalassemia
branden moriarty
broad institute
cas13
crispr therapeutics
crispr-cas9
dacogen
david liu
deals
decitabine
editas medicine
editor
editr
enzyme
epigenetics
epizyme
farydak
feng zhang
flagship pioneering
fulcrum therapeutics
gene editing
harvard university
insulated genomic domains
intellia therapeutics
john evans
kaleido biosciences
keith joung
What
startup
2
×
therapeutics
aims
approach
based
beam
biotech
called
cas
crispr
debuts
developing
drugs
editas
editing
editor
epigenetic
epigenetics
field
flagship’s
founders
gene
gotten
harvard
jump
mass
medicine
medicines
morning
new
omega
precise
research
scientists
spotlights
step
touting
university
version
Language
unset
Current search:
dna
×
startup
×
" san francisco blog main "
×
@xconomy.com
4 years ago
Flagship’s Omega Aims to Take Epigenetic Drugs a Step Further
@xconomy.com
5 years ago
Beam Therapeutics Spotlights CRISPR 2.0 with Precise Gene Editor, $87M
